Curaleaf and Surterra are top spenders on federal marijuana lobbying

The marijuana industry has spent about $2 million so far this year lobbying for federal cannabis reform in Washington DC, and more than half that money has come from individual MJ-related companies. Businesses and lobbying organizations said the investments are critical in helping lawmakers and federal regulators understand the importance of cannabis-related issues. They are focusing on vexing industry problems such as banking, as well as broader reform and legalization efforts. The payoff co...